FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Henk Out

Research Profile

Chemicals & Drugs

Procedures

Disorders

Female Infertility

Co-author Network

Publications

TOP 3
Henk J Out; Bernadette M J L Mannaerts
The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.
Henk J Out; E H Hoomans; W N de Laat
Meta analysis on rFSH versus uFSH.
Henk J Out; H J Bennink; W N de Laat
What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Henk Out (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Henk J Out; Bernadette M J L Mannaerts
The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.
Human fertility (Cambridge, England) 2002;5(1):G5-10; discussion G10-2, G41-8.
2001: Henk J Out; E H Hoomans; W N de Laat
Meta analysis on rFSH versus uFSH.
Human reproduction (Oxford, England) 2001;16(3):593-5.
1999: Henk J Out; H J Bennink; W N de Laat
What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.
Human reproduction (Oxford, England) 1999;14(9):2189-90.
1999: Henk J Out
New stimulation regimens with recombinant FSH (Puregon) in in-vitro fertilization.
European journal of obstetrics, gynecology, and reproductive biology 1999;85(1):21-2.
1999: Henk J Out; svend lindenberg; Anne Lis Mikkelsen; Talia Eldar-Geva; David L Healy; A Leader; F J Rodriguez-Escudero; J A Garcia-Velasco; A Pellicer
A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation.
Human reproduction (Oxford, England) 1999;14(3):622-7.
1998: C A Jansen; H C van Os; Henk J Out; Herjan J T Coelingh Bennink
A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.
Human reproduction (Oxford, England) 1998;13(11):2995-9.
1998: Henk J Out; Herjan J T Coelingh Bennink
Clomiphene citrate or gonadotrophins for induction of ovulation?
Human reproduction (Oxford, England) 1998;13(9):2358-61.
1998: Herjan J T Coelingh Bennink; Bart CJM Fauser; Henk J Out
Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
Fertility and sterility 1998;69(1):19-25.
1997: Ingrid J M Duijkers; Christine Klipping; TM Mulders; Henk J Out; Herjan J T Coelingh Bennink; HM Vemer
Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations.
Human reproduction (Oxford, England) 1997;12(11):2379-84.
1997: HOWARD JONES; Henk J Out; E H Hoomans; S G Driessen; Herjan J T Coelingh Bennink
Cryopreservation: the practicalities of evaluation.
Human reproduction (Oxford, England) 1997;12(7):1522-4.
1997: Henk J Out; S G Driessen; Bernadette M J L Mannaerts; Herjan J T Coelingh Bennink
Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins.
Fertility and sterility 1997;68(1):138-42.
1997: Henk J Out; W Olijve; Herjan J T Coelingh Bennink
"The coming of wonders".
Fertility and sterility 1997;67(2):411-3.
1997: Henk J Out; P E Reimitz; H J Bennink
A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon).
Fertility and sterility 1997;67(2):278-83.
1996: Henk J Out; Bernadette M J L Mannaerts; S G Driessen; H J Coelingh Bennink
Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies.
Human reproduction update 1996;2(2):162-71.
1996: Bernadette M J L Mannaerts; F Rombout; Henk J Out; H Coelingh Bennink
Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy.
Human reproduction update 1996;2(2):153-61.
1996: Henk J Out; P G Schnabel; F Rombout; T B Geurts; M A Bosschaert; H J Coelingh Bennink
A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin.
Human reproduction (Oxford, England) 1996;11(1):61-3.
1995: B Hedon; Henk J Out; Jean-Noel Hugues; B Camier; J Cohen; P Lopes; J R Zorn; B van der Heijden; H J Coelingh Bennink
Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial.
Human reproduction (Oxford, England) 1995;10(12):3102-6.
1995: Henk J Out; Bernadette M J L Mannaerts; S G Driessen; H J Bennink
A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.
Human reproduction (Oxford, England) 1995;10(10):2534-40.